Welcome to LookChem.com Sign In|Join Free

CAS

  • or

149507-27-7

Post Buying Request

149507-27-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

149507-27-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 149507-27-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,9,5,0 and 7 respectively; the second part has 2 digits, 2 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 149507-27:
(8*1)+(7*4)+(6*9)+(5*5)+(4*0)+(3*7)+(2*2)+(1*7)=147
147 % 10 = 7
So 149507-27-7 is a valid CAS Registry Number.
InChI:InChI=1/C15H17NO2/c16-11-12-1-3-13(4-2-12)14-5-7-15(8-6-14)17-9-10-18-15/h1-4,14H,5-10H2

149507-27-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-(1,4-dioxaspiro[4.5]decan-8-yl)benzonitrile

1.2 Other means of identification

Product number -
Other names 4-(1,4-dioxa-spiro[4.5]dec-8-yl)-benzonitrile

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:149507-27-7 SDS

149507-27-7Relevant articles and documents

NOVEL BRONCHODILATING DIAZAHETEROARYLS

-

, (2012/03/08)

The invention relates to novel compounds having the general formula (I), and which compounds are useful to treat a disorder or disease characterized by bronchoconstriction, e.g. COPD and asthma.

NOVEL BRONCHODILATING DIAZAHETEROARYLS

-

Page/Page column 128-129, (2010/09/17)

The invention relates to novel compounds having the general formula (I), and which compounds are useful to treat a disorder or disease characterized by bronchoconstriction, e.g. COPD and asthma.

Cyclic imino derivatives and pharmaceutical compositions containing them

-

, (2008/06/13)

The invention relates to cyclic imino compounds which have, inter alia, valuable pharmacological properties, especially inhibitory effects on cell aggregation, pharmaceutical compositions which contain these compounds and processes for preparing them.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 149507-27-7